Clinical Trials Logo
  1. Home
  2. Female Sexual Dysfunction
  3. NCT06060691
  4. Details
NCT06060691 Clinical Trial

the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction

Female Sexual Dysfunction Clinical Trial

Official title:
Randomized Controlled Trial Studying the Ameliorating Effects of Kaempferol Emulgel on Female Arousal Disorder and Sexual Dysfunction

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06060691
Other study ID # 5/23
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date September 20, 2023
Est. completion date February 1, 2024

Study information
Verified date May 2024
Source Deraya University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the quality of sexual life of females with sexual interest or arousal disorder before and after accurate application of a formulated emulgel made from natural ingredients, including kaempferol as an API

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date February 1, 2024
Est. primary completion date December 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 28 Years to 45 Years
Eligibility Inclusion Criteria: - Women between the ages of 28 and 45 - had regular periods and previous menstrual bleeding lasted between three and seven days Exclusion Criteria: - sensitivity to drug of therapy, - cancer, - autoimmune illness, - smoking or drinking, - liver disease, - irregular menstruation

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Kaempferol
Kaempferol

Locations
Country Name City State
Egypt Soad A. Mohamad Minya

Sponsors (1)
Lead Sponsor Collaborator
Deraya University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Female Sexual Function Index The FSFI comprises 19 questions of sexual function in six independent areas consisting of desire, arousal, lubrication, orgasm, sexual satisfaction , pain from sex. two months
See also
  Status Clinical Trial Phase
Completed NCT05806424 - Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
Completed NCT01364623 - PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women Phase 1
Recruiting NCT04419961 - Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester N/A
Completed NCT04122703 - Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction N/A
Recruiting NCT03498443 - Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
Completed NCT03232801 - A Mindfulness-based Intervention for Older Women With Low Sexual Desire N/A
Completed NCT04124640 - Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
Completed NCT00995072 - Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function N/A
Active, not recruiting NCT05168371 - Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction N/A
Completed NCT04384172 - Effect of Peripheral Neuromodulation on Vaginal Blood Flow N/A
Recruiting NCT06237166 - Evaluation of an Online Intervention for Female Sexual Dysfunction N/A
Completed NCT03463707 - BP101 for Adults With Female Sexual Dysfunction Phase 3
Recruiting NCT01078077 - The Impact of a Topical Vasodilating Cream on Female Sexual Experience N/A
Completed NCT01724658 - Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women Phase 2
Completed NCT02229721 - Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women Phase 2
Completed NCT00479570 - Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. Phase 2
Not yet recruiting NCT06116045 - Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder Phase 2
Withdrawn NCT02862184 - Female Sexual Dysfunction, Risks and Outcomes (FSFI) N/A
Completed NCT01195701 - Clitoral Location in Relation to Sexual Function Using Pelvic Imaging N/A
Completed NCT04484753 - Validation of iPelvis App for Female Pelvic Floor Dysfunction N/A